bioRxivNeurosciencePreprint
5-HAYED peptide can protect AD brain by scavenging the redundant iron ions and the catalyzed radicals
Zhenyou ZouiD, Shengxi ShaoiD, Li Li, Xiaoying Cheng, Qiqiong Shen
Abstract
Alzheimers disease (AD) is a progressive neurodegenerative disease characterized by memory and cognitive decline. It is incurable currently and places a great burden on the caregivers of patients. Iron is rich in the brain of AD suffers. It catalyzes radicals which impairs neurons. Therefore, reducing the redundant brain iron is pressing to ease AD. To scavenge the excessive brain iron catalyzed radical, thus protect the brain and decrease the incidence of AD. We synthesized a soluble iron-pro 5-HAYED peptide. By injecting 5-HAYED to the cerebrospinal fluid (CSF) of the AD mouse, we observed that the 5-HAYED is able to decrease the brain iron and radical level, which behaving neurons protection, and can ameliorate the cognition status for AD mouse. Further, 5-HAYED can decreased the AD incidence and can reverse the AD associated anemia and inflammation without hurt kidney and liver.
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Iron associated lipid peroxidation in Alzheimers disease is increased in lipid rafts with decreased ferroptosis suppressors, tested by chelation in mice
Max Andrew Thorwald, José A. Godoy-Lugo, … Caleb E. Finch·Alzheimer s & DementiaPeer-reviewed·Jan 1, 2025
- FAAH Inhibition as a Path to Mitigate Alzheimer's Disease Progression in Mouse Models of Amyloidosis
Sergio Oddi, Lucia Scipioni, … Mauro Maccarrone·FEBS JournalPeer-reviewed·Jan 16, 2025
- The Neuroprotective Beta Amyloid Hexapeptide Core Reverses Deficits in Synaptic Plasticity in the 5xFAD APP/PS1 Mouse Model
Kelly H. Forest, Ruth Taketa, … Robert A. Nichols·Frontiers in Molecular NeurosciencePeer-reviewed·Apr 12, 2021
- Behavioral and neuropathological features of Alzheimer's disease are attenuated in 5xFAD mice treated with intranasal GHK peptide
Matthew Tucker, Gerald Yu Liao, … Warren Ladiges·Aging Pathobiology and TherapeuticsPeer-reviewed·Sep 23, 2024
- Effects of Alzheimer's disease and formalin fixation on the different mineralised-iron forms in the human brain
L. van der Weerd, A. Lefering, … L. Bossoni·Scientific ReportsPeer-reviewed·Oct 5, 2020
- Amyloid-β exposed astrocytes induce iron transport from endothelial cells at the blood-brain barrier by altering the ratio of apo- and holo-transferrin
Stephanie L. Baringer, Avraham S. Lukacher, … James R. Connor·Journal of NeurochemistryPeer-reviewed·Sep 4, 2023